New Orleans, LA — December 8, 2024 — PharmID is excited to introduce its latest integration between the WasteWitness® controlled substance waste monitoring system and Codonics Safe Label System® (SLS) syringe label barcodes at the ASHP Midyear Clinical Meeting in New Orleans on December 8. This innovative integration enhances safety, compliance, and chain of custody for controlled substances from dispensing to waste disposal, providing healthcare facilities with a streamlined, closed-loop solution to improve medication handling integrity.

The integration with Codonics SLS allows WasteWitness to recognize SLS syringe label barcodes instantly, identifying and verifying controlled substances at the point of disposal. This integration facilitates secure, real-time verification, simplifying workflows and supporting stringent compliance protocols, while enhancing chain of custody throughout the controlled substance lifecycle.

“By integrating SLS syringe label barcodes into WasteWitness, we not only enhance safety but also significantly improve clinical efficiency,” said James DePoy, CEO of PharmID. “This integration minimizes repetitive data entry, ensuring smoother workflows for clinical staff, while maintaining high levels of compliance and accuracy in controlled substance waste management.”

Mike Kolberg, Vice President of Codonics, emphasized the value of this collaboration: “The ability for companies like PharmID to support SLS syringe label barcodes helps enable diversion control for improved patient care. This integration reflects Codonics’ commitment to enhancing medication safety and operational efficiency for healthcare providers.”

Enhanced Safety and Efficiency for High-Risk Areas

Ideal for high-risk areas such as operating rooms and emergency departments, WasteWitness combined with Codonics SLS syringe label barcodes allows healthcare providers to manage controlled substance waste securely, preventing diversion risks and supporting compliance standards. This new integration represents a significant advancement in medication workflow integrity, helping healthcare facilities simplify processes and improve controlled substance monitoring.

PharmID invites ASHP Midyear attendees to visit their booth on December 8 to experience the enhanced WasteWitness capabilities firsthand and learn how this solution strengthens safety and compliance across healthcare settings.

About Codonics

Founded in 1982 and headquartered in Cleveland, Ohio, Codonics is a global healthcare technology leader with a presence in 110 countries and over 65,000 installations. Renowned for innovative solutions like the award-winning Safe Label System® —a standard of care for medication safety in leading hospitals worldwide—Codonics is committed to advancing patient outcomes. By developing technologies that enhance safety, efficiency, and standardization, Codonics empowers clinicians to provide safer, more effective healthcare. Learn more at codonics.com.

About PharmID

PharmID, headquartered in Kirkland, WA, is a pioneering provider of cutting-edge solutions for controlled substance management, dedicated to enhancing safety, compliance, and efficiency in healthcare. Through its innovative WasteWitness® system and other advanced technologies, PharmID supports hospitals, pharmacies, and healthcare organizations nationwide in preventing diversion, ensuring regulatory compliance, and safeguarding patient safety. For more information on PharmID and the WasteWitness® system, visit pharmid.com.

Contact:

Robb Young | Head of Partnerships | robby@pharmid.com